News

AFT welcomes us fda complete response letter

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has received a US Food and Drug Administration (FDA) complete response letter (CRL).

Read More

AFT appoints Anita Baldauf as a director

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) has today appointed Anita Baldauf as a non-executive director.

Read More

AFT and Setek sign supply agreement

Agreement covers pharmaceutical-grade medicinal cannabis ingredients for products initially targeted for Australia and New Zealand

Read More

Maxigesic IV® distribution deals signed in UK and Hong Kong

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) has signed exclusive Maxigesic IV® distribution and supply agreements for the UK and Hong Kong, with the company targeting sales of the medicine in these territories in 2022.

Read More

Kiwi Health Flagship Store Launches in China on Tmall Global

ASX-listed RooLife (ASX:RLG) and ASX and NZX-listed AFT Pharmaceuticals (ASX:AFP, NZX:AFT) have officially launched the New Zealand branded online health and pharmacy store in China – “Kiwi Health”

Read More

AFT Pharmaceuticals to announce half year interim results on Thursday November 19 2020

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Thursday November 19 2020 its half year interim results for the period ended September 30 2020. The release will be issued at around 09:00.

Read More

Notice of Adjourned Annual Meeting of Shareholders 2020

Notice is hereby given that the adjourned Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or the Company) will be convened and held on a fully virtual basis on Tuesday, 8 September 2020 commencing at 10.30am (New Zealand time) to transact the business set out in the Notice of Annual Meeting of Shareholders 2020 dated 15 July 2020 (Original AGM Notice).

Read More

Urgent Adjournment of 2020 Annual Meeting

AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) advises that the Annual Meeting of shareholders of AFT scheduled for 10.30am (NZ time) today will be adjourned to a time and date to be advised. This follows the Government’s announcement that the Auckland Region will move to COVID-19 alert level 3 today, which means that shareholders should stay home and refrain from attending the meeting.

Read More

Maxigesic IV® licensed in six new European nations

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) has signed an exclusive Maxigesic IV® licensing and supply agreement for Bulgaria, Cyprus, the Czech Republic, Hungary, Romania and Slovakia, countries with a combined population of more than 53 million*.

Read More

New Zealand codeine restrictions set for November

AFT Pharmaceuticals (NZX:AFT, ASX:AFT) today welcomes Medsafe’s announcement that all codeine and codeine-containing medicines will become prescription only from 5 November 2020.

Read More

Notice of Annual Meeting of Shareholders 2020

Notice is hereby given that the Annual Meeting of shareholders of AFT Pharmaceuticals Limited (*AFT or the Company*) will be held at the Milford Cruising Club, 24 Craig Road, Milford, Auckland, New Zealand, on *Wednesday, 12 August 2020 commencing at 10.30am* (New Zealand time).

Read More

RooLife & AFT launch Online New Zealand Health Store in China

RooLife partners with ASX & NZX-listed AFT Pharmaceuticals (ASX:AFP, NZX:AFT) to deliver New Zealand branded online health & pharmacy store in China

Read More